Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Longda New-Tech Bio-pharmacy is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of veterinary medicines and animal health products. The company produces a wide range of formulations including powders, injections, and premixes designed to treat infectious, respiratory, and gastrointestinal diseases in livestock and poultry. Longda New-Tech operates large-scale manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure product quality and safety. Their business model focuses on providing comprehensive health solutions for the agricultural sector, supporting both domestic and international markets with therapeutic and preventive animal healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longda New-Tech Bio-pharmacy.